Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa
Top Cited Papers
Open Access
- 1 August 2001
- Vol. 92 (3) , 657-662
- https://doi.org/10.1002/1097-0142(20010801)92:3<657::aid-cncr1367>3.0.co;2-d
Abstract
BACKGROUND Gain‐of‐function mutations of the c‐kit protooncogene, mainly clustered in the juxtamembrane domain, have been reported in a significant fraction of gastrointestinal (GI) stromal tumors (GISTs) that represent the most common mesenchymal tumor of the GI tract. Two families also have been described with a GIST predisposition syndrome with a germline c‐kit mutation affecting either the juxtamembrane domain or the tyrosine kinase domain. Here, the authors report on a family in which the dominantly inherited trait of hyperpigmented spots was inherited from an individual who developed multiple GISTs with diffuse hyperplasia of the myenteric plexus by his son, who was affected with urticaria pigmentosa. METHODS Screening for the c‐kit mutation was performed by means of polymerase chain reaction‐based denaturing gradient gel electrophoresis/constant denaturing gel electrophoresis followed by direct sequencing of abnormal conformers. Expression of KIT and CD34 was determined by immunohistochemistry. RESULTS In peripheral blood DNA samples, both affected family members showed a previously undescribed c‐kit mutation in the juxtamembrane domain, resulting in the substitution of alanine for valine559. Mutation and polymorphic marker analyses on DNA samples from three GISTs and two skin biopsy specimens evidenced the same mutation in the heterozygous condition. Immunohistochemical examination showed coexpression of CD117 (c‐kit) and CD34 in all independent GISTs and CD117 positivity in mast cells from the skin lesions. CONCLUSIONS Comparative analysis of clinical presentation and mutation mapping in the families described to date point to the peculiar association of mast cells, melanocytic dysfunction, and GIST predisposition in carriers of c‐kit mutations within the juxtamembrane domain. Cancer 2001;92:657–62. © 2001 American Cancer Society.Keywords
This publication has 20 references indexed in Scilit:
- Germline-Activating Mutation in the Kinase Domain of KIT Gene in Familial Gastrointestinal Stromal TumorsThe American Journal of Pathology, 2000
- KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal TumorsThe American Journal of Pathology, 2000
- C‐kit Gene Abnormalities in Gastrointestinal Stromal Tumors (Tumors of Interstitial Cells of Cajal)Japanese Journal of Cancer Research, 1999
- Activating c-kit Gene Mutations in Human Germ Cell TumorsThe American Journal of Pathology, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Role of c‐kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cellsPathology International, 1996
- Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmNature Genetics, 1996
- c-kit point mutation of extracellular domain in patients with myeloproliferative disordersBritish Journal of Haematology, 1995
- W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activityNature, 1995
- Role of the KIT protooncogene in normal and malignant human hematopoiesis.Proceedings of the National Academy of Sciences, 1992